Comparison of Treatment Outcomes Between Topical and Systemic Therapies for Psoriasis

Chapter ONE

INTRODUCTION

• 1.1Introduction
• 1.2Background of the Study: Psoriasis Treatment Modalities
• 1.3Statement of the Problem: Comparing Efficacy of Topical vs. Systemic Treatments
• 1.4Aim and Objectives of the Study   - Aim: To evaluate and compare treatment outcomes of topical and systemic therapies for psoriasis   - Specific Objectives: Assess clinical improvements, side-effect profiles, patient satisfaction, and treatment adherence in both groups
• 1.5Research Questions   - What are the clinical outcomes of topical versus systemic therapies in psoriasis patients?   - How do side effects influence treatment adherence in both groups?   - Which therapy yields higher patient satisfaction?
• 1.6Research Hypotheses   - Null Hypothesis: No significant difference exists in treatment outcomes between topical and systemic therapies   - Alternative Hypothesis: Significant differences exist in treatment outcomes between the two therapies
• 1.7Significance of the Study   - To inform clinical decision-making in psoriasis treatment   - To contribute to evidence-based dermatology practices   - To guide patient counseling on treatment options
• 1.8Scope and Delimitation of the Study   - Focus on adult patients diagnosed with plaque psoriasis in dermatology clinics   - Comparison between selected topical treatments (e.g., corticosteroids, vitamin D analogs) and systemic treatments (e.g., methotrexate, biologics)
• 1.9Limitations of the Study   - Potential variability in patient adherence   - Ethical considerations restricting certain experimental interventions   - Limitations inherent in observational data
• 1.10Organisation of the Study   - Chapter summaries; methodology; results; discussion; conclusion
• 1.11Operational Definition of Terms   - Psoriasis, Topical Therapy, Systemic Therapy, Treatment Outcome, Clinical Improvement, Patients Satisfaction, Treatment Adherence

Chapter TWO

LITERATURE REVIEW

• 2.1Conceptual Review of Psoriasis and Therapeutic Approaches
• 2.2Definitions and Classifications of Psoriasis
• 2.3Overview of Topical Treatments for Psoriasis
• 2.4Overview of Systemic Treatments for Psoriasis
• 2.5Theoretical Framework: Health Belief Model and Transtheoretical Model in Treatment Adherence
• 2.6Empirical Review of Prior Studies Comparing Topical and Systemic Therapies
• 2.7Comparative Effectiveness of Topical versus Systemic Treatments: Meta-Analyses and Systematic Reviews
• 2.8Side-Effect Profiles and Safety Considerations of Both Treatment Modalities
• 2.9Patient Satisfaction and Quality of Life Outcomes
• 2.10Factors Influencing Treatment Adherence in Psoriasis Patients
• 2.11Gaps in Existing Literature and Rationale for the Study
• 2.12Conceptual Model or Summary of Literature Review Findings

Chapter THREE

RESEARCH METHODOLOGY

• 3.1Research Design: Comparative Cross-Sectional Study
• 3.2Philosophical Paradigm: Pragmatism
• 3.3Population of the Study: Adults with Diagnosed Psoriasis Receiving Therapy
• 3.4Sample Size and Sampling Technique: Calculated via Cochran’s formula; Stratified Random Sampling
• 3.5Sources of Data: Patient records, structured questionnaires, clinical assessments
• 3.6Instruments of Data Collection: Validated questionnaires, clinical outcome scales (e.g., PASI)
• 3.7Validity and Reliability of Instruments   - Pilot testing, expert validation, Cronbach’s alpha
• 3.8Data Analysis Methods: Descriptive statistics, t-tests, chi-square tests, multivariate regression
• 3.9Analytical Framework: Comparative effectiveness analysis models
• 3.10Ethical Considerations   - Informed consent, confidentiality, ethical approval from review board

Chapter FOUR

DATA PRESENTATION AND ANALYSIS

• ANALYSIS AND DISCUSSION OF FINDINGS
• 4.1Data Presentation: Demographic and Baseline Characteristics
• 4.2Descriptive Analysis of Treatment Outcomes for Topical and Systemic Groups
• 4.3Hypotheses Testing: Comparing PASI scores, Side Effects, Satisfaction Levels
• 4.4Interpretation of Results: Clinical Significance and Statistical Validity
• 4.5Factors Influencing Treatment Success and Compliance
• 4.6Discussion of Findings in Relation to Literature Review
• 4.7Limitations in Data and Analytical Constraints
• 4.8Implications for Practice and Policy

Chapter FIVE

SUMMARY, CONCLUSION AND RECOMMENDATIONS

• CONCLUSION AND RECOMMENDATIONS
• 5.1Summary of Key Findings
• 5.2Conclusions Drawn from the Study
• 5.3Contributions to Knowledge
• 5.4Recommendations for Clinicians and Stakeholders
• 5.5Suggestions for Further Research
• 5.6Final Remarks